The aim of this study was to apply the model to virtual breast cancer populations capturing the respective CYP2D6 allele frequencies, simulate tamoxifen standard dosing for each biogeographical group, and determine the frequency of patients with subtarget CSS,min ENDX. This evidence concerns the gene CYP2D6 and breast cancer.